Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities
Loss from continuing operations	$ (133,574)	$ (257,091)
Less: Income (Loss) from discontinued operations, net of tax	4,003	(33,764)
Net loss from continuing operations	(137,577)	(223,327)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	17,755	19,766
Stock-based compensation	26,744	30,291
Amortization of debt discount	1,268	1,219
Deferred income tax benefit	(235)	(758)
Change in fair value of warrant liabilities	0	1,701
Amortization of right-of-use assets	1,359	1,721
Other adjustments	319	653
Changes in operating assets and liabilities of business, net of acquisitions:
Accounts receivable, net	(4,828)	2,465
Prepaid expenses and other assets	(5,169)	13,669
Prepaid sports rights	1,127	(38,687)
Accounts payable	(20,716)	(3,284)
Accrued expenses and other liabilities	(22,845)	(6,700)
Deferred revenue	(4,659)	(1,962)
Lease liabilities	(610)	604
Net cash used in operating activities - continuing operations	(148,067)	(202,629)
Net cash used in operating activities - discontinued operations	(1,232)	(14,369)
Net cash used in operating activities	(149,299)	(216,998)
Cash flows from investing activities
Purchase of short-term investments	0	(100,000)
Purchases of property and equipment	(267)	(962)
Capitalization of Internal Use Software	(8,404)	(1,949)
Net cash used in investing activities - continuing operations	(8,671)	(102,911)
Net cash used in investing activities - discontinued operations	0	(4,255)
Net cash used in investing activities	(8,671)	(107,166)
Cash flows from financing activities
Proceeds from the issuance of common stock, net of offering costs	116,903	220,188
Redemption of non-controlling interest	(2,147)	0
Vested restricted stock units settled for cash	(125)	0
Proceeds from exercise of stock options	95	572
Proceeds from the exercise of warrants	0	5,000
Repayments of notes payable and long-term borrowings	(326)	(1,359)
Net cash provided by financing activities - continuing operations	114,400	224,401
Net cash provided by financing activities - discontinued operations	0	0
Net cash provided by financing activities	114,400	224,401
Net decrease in cash, cash equivalents and restricted cash	(43,570)	(99,763)
Cash, cash equivalents and restricted cash at beginning of period	343,226	376,080
Cash, cash equivalents and restricted cash at end of period	299,656	276,317
Supplemental disclosure of cash flows information:
Interest paid	6,579	6,639
Income taxes paid	6	0
Non-cash financing and investing activities:
Shares settled liability	3,670	0
Reclassification of the equity components of the 2026 Convertible Notes to liability upon adoption of ASU 2020-06	0	75,264
Cashless exercise of warrants	0	5,249
Accrued expenses - Issuance of common stock	$ 9	$ 0